Saturday, July 11, 2026

pharma · Dry Eye Disease

First Biotech (Australia)

First Biotech (Australia) clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Melbourne, AU HQ
2017 Founded
2 Employees
TGA registrant Type
Company details
Status
Public
HQ
Melbourne, AU
Founded
2017
Employees
2
Programs
1
Drugs
4
Patents
0
Intelligence · Clinical Programs

First Biotech (Australia) projects

1 ClinicalTrials.gov programs sponsored by First Biotech (Australia).

First Biotech (Australia) has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Hydroxypropyl Guar Galactomannan

    Alcon Laboratories (Australia) Pty Ltd

    Dry Eye Disease

    phase 2 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does First Biotech (Australia) have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.